ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

May 30, 2008

Stereotactic Radiosurgery Improves Survival Without Whole-Brain Radiotherapy

September 27, 2013

Tobaccos Council Awards New Grants

April 3, 1981

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

Book Related History Of Cancer Act

March 3, 1978